Chloraprep One-step Solution
NDC Package 54365-400-07
Package Information
Chloraprep One-step (chlorhexidine gluconate and isopropyl alcohol) solution is • use with care in premature infants or infants under 2 months of age.These products may cause irritation or chemical burns.• maximal treatment area for one applicator is approximately 2.5 in. This formulation utilizes a solution delivery system. Marketed by Carefusion 213 Llc, this product is identified by NDC 54365-400 and is authorized under FDA application NDA021555.
Identification & Billing
- RxCUI: 858726 - chlorhexidine gluconate 2 % / isopropyl alcohol 70 % Topical Solution
- RxCUI: 858726 - chlorhexidine gluconate 20 MG/ML / isopropyl alcohol 0.7 ML/ML Topical Solution
- RxCUI: 998282 - ChloraPrep 2 % / 70 % Topical Solution
- RxCUI: 998282 - chlorhexidine gluconate 20 MG/ML / isopropyl alcohol 0.7 ML/ML Topical Solution [ChloraPrep]
- RxCUI: 998282 - ChloraPrep (chlorhexidine gluconate 2 % / isopropyl alcohol 70 % ) Topical Solution
Clinical Specifications
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- CHLORHEXIDINE GLUCONATE 20 mg/mL
- ISOPROPYL ALCOHOL .7 mL/mL
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
- Decreased Cell Wall Integrity - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 54365 - Carefusion 213 Llc
- 54365-400 - Chloraprep One-step
- 54365-400-07 - 48 POUCH in 1 CARTON / 1 APPLICATOR in 1 POUCH / 1.75 mL in 1 APPLICATOR
- 54365-400 - Chloraprep One-step
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54365-400). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54365-400-07 identifies a specific commercial package of 48 pouch in 1 carton / 1 applicator in 1 pouch / 1.75 ml in 1 applicator of Chloraprep One-step, a human over the counter drug labeled by Carefusion 213 Llc. This solution is formulated for topical use and contains chlorhexidine gluconate; isopropyl alcohol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Carefusion 213 Llc on October 07, 2002. The current certification is valid through December 31, 2026.
How is this Carefusion 213 Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54365040007. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.